Chronic Obstructive Pulmonary Disease (COPD): Treatment and Management—Second Edition
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Respiratory Medicine".
Deadline for manuscript submissions: 31 August 2026
Special Issue Editors
Interests: lung; spirometry; lung diseases; airway obstruction; asthma management; ventilation; respiratory physiology; allergic diseases; diagnosis; inflammatory bowel disease
Special Issues, Collections and Topics in MDPI journals
2. Cardio-Thoracic and Vascular Department, University Hospital of Parma, 43126 Parma, Italy
Interests: asthma; lung; sputum; lung diseases; spirometry; airway obstruction; respiratory physiology; cystic fibrosis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are delighted to launch the second edition of our Special Issue titled “Chronic Obstructive Pulmonary Disease (COPD): Treatment and Management—Second Edition”. We invite you to visit our website to access the first volume of this Special Issue, available at https://www.mdpi.com/journal/jcm/special_issues/DFT93K98XY.
Chronic obstructive pulmonary disease (COPD) is a major global health problem due to its high prevalence (10% of the adult population), rising incidence, and very significant associated personal, social, and economic costs. The old view that COPD is a single disease caused by smoking and characterized by an accelerated rate of lung function decline that occurs in (mostly) older males is outdated and incomplete. Recent data support a different pathogenic paradigm that considers that COPD is a polygenic disease with a significant epigenetic component and multiple environmental risk factors that interact and accumulate through life in complex ways to determine the clinical manifestations. Although few novel treatments have been approved for COPD in the past 5 years, advances have been made in targeting specific subpopulations with existing therapies using new biomarker-based strategies. Additionally, COVID-19 has undeniably affected individuals with COPD, who are not only at higher risk for severe disease manifestations than healthy individuals but are also negatively affected by interruptions in healthcare delivery and social isolation. This Special Issue reviews COPD with an emphasis on recent advances in epidemiology, imaging, diagnosis, and treatment.
Dr. Maurizio Marvisi
Prof. Dr. Alfredo Antonio Chetta
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- chronic obstructive pulmonary disease (COPD)
- treatable traits
- precision medicine
- COPD comorbidities
- COPD mortality
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
